| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.48B | 28.36B | 24.86B | 27.14B | 24.26B | 21.19B |
| Gross Profit | 18.83B | 18.00B | 14.71B | 16.00B | 15.33B | 12.87B |
| EBITDA | 12.22B | 11.38B | 8.83B | 9.97B | 9.61B | 7.46B |
| Net Income | 8.01B | 7.50B | 5.53B | 6.01B | 6.37B | 4.71B |
Balance Sheet | ||||||
| Total Assets | 52.37B | 54.84B | 49.64B | 44.90B | 40.89B | 35.22B |
| Cash, Cash Equivalents and Short-Term Investments | 24.58B | 26.11B | 27.04B | 24.18B | 19.52B | 16.67B |
| Total Debt | 422.00M | 457.97M | 788.63M | 1.11B | 1.32B | 1.34B |
| Total Liabilities | 4.81B | 7.03B | 7.39B | 7.04B | 7.73B | 7.52B |
| Stockholders Equity | 47.56B | 47.81B | 42.25B | 37.86B | 33.17B | 27.70B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.97B | 5.41B | 6.83B | 4.68B | 6.14B |
| Operating Cash Flow | 0.00 | 8.43B | 6.03B | 7.84B | 5.09B | 6.78B |
| Investing Cash Flow | 0.00 | -5.22B | -781.53M | -324.68M | 1.04B | -557.87M |
| Financing Cash Flow | 0.00 | -3.65B | -3.06B | -2.86B | -2.87B | -2.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥86.91B | 7.61 | ― | 3.02% | 1.66% | 11.28% | |
74 Outperform | ¥158.25B | 14.73 | ― | 2.84% | 6.06% | 19.76% | |
74 Outperform | ¥166.07B | 8.76 | 6.23% | 1.11% | 2.88% | 16.60% | |
73 Outperform | ¥138.74B | 13.67 | ― | 1.58% | 11.77% | 27.55% | |
70 Outperform | ¥115.79B | 6.63 | ― | 4.15% | 1.16% | 167.89% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥161.64B | 9.97 | 4.24% | 3.76% | -7.81% | 25.04% |